Cephalic Vein Cut-down for Totally Implantable Central Venous Access Devices With Preoperative Ultrasonography by Surgical Residents
Authors
Affiliations
Background/aim: Cephalic vein (CV) cut-down for totally implantable central venous access devices (TICVADs) is not frequently used due to its low success rate. We compared the outcomes of CV cut-down using preoperative ultrasonography (US) performed by experienced surgeons versus surgical residents.
Patients And Methods: From December 2015 to December 2017, 10 surgeons implanted 212 TICVADs using CV cut-down with preoperative US. The surgeons were divided into two groups of five each: surgical residents (Group A, n=124 procedures) and experienced surgeons (Group B, n=88 procedures). Duration of operation time, completion rate, and complications were retrospectively analyzed.
Results: The completion rate was significantly higher in Group A (98.4% versus 92.0%, p=0.04). Duration of operation time (45.2±14.5 versus 42.0±13.1 minutes, p=0.22), rates of early complications (1.6% versus 1.1%, p=0.77) and late complications (3.2% versus 2.3%, p=0.68) were equivalent between the two groups. No fatal complications occurred in either group.
Conclusion: CV cut-down can be safely performed by surgical residents under the use of preoperative US.
Chang Y, Chen N, Huang S, Lai C, Chen C, Chang T Sci Rep. 2023; 13(1):13732.
PMID: 37612418 PMC: 10447542. DOI: 10.1038/s41598-023-40755-9.
Obuchi K, Imaizumi K, Kasajima H, Kurushima M, Umehara M, Tsuruga Y In Vivo. 2022; 36(2):985-993.
PMID: 35241560 PMC: 8931890. DOI: 10.21873/invivo.12791.
Toro A, Schembari E, Fontana E, Di Saverio S, Di Carlo I Langenbecks Arch Surg. 2021; 406(6):1739-1749.
PMID: 34109472 PMC: 8481188. DOI: 10.1007/s00423-021-02225-6.
Long-Term Results of a Standard Algorithm for Intravenous Port Implantation.
Wu C, Fu J, Wen C, Chiu C, Hsieh M, Liu Y J Pers Med. 2021; 11(5).
PMID: 33923312 PMC: 8146737. DOI: 10.3390/jpm11050344.
Otsubo R, Yano H, Matsumoto M, Tanaka A, Nonaka T, Hidaka S In Vivo. 2021; 35(2):1197-1204.
PMID: 33622921 PMC: 8045093. DOI: 10.21873/invivo.12369.